- Author's Reply
-
Hiraoka S, Kato J, Okada H
- KMID: 2417688
- Intest Res.
- 2018 Apr;16(2):321-322.
- doi: 10.5217/ir.2018.16.2.321
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
-
Kato J, Hiraoka S, Nakarai A, Takashima , Inokuchi T, Ichinose M
- KMID: 2174504
- Intest Res.
- 2016 Jan;14(1):5-14.
- doi: 10.5217/ir.2016.14.1.5
Accurate evaluation of disease activity is essential for choosing an appropriate treatment and follow-up plan for patients with inflammatory bowel disease (IBD). Endoscopy is required for accurately evaluating disease activity,... -
- CITED
-
- Close
- SHARE
-
- Close
- Fecal Immunochemical Test and Fecal Calprotectin Results Show Different Profiles in Disease Monitoring for Ulcerative Colitis
-
Hiraoka S, Inokuchi T, Nakarai A, Takashima , Takei D, Sugihara Y, Takahara M, Harada K, Okada H, Kato J
- KMID: 2429068
- Gut Liver.
- 2018 Mar;12(2):142-148.
- doi: 10.5009/gnl17013
BACKGROUND/AIMS: Both fecal immunochemical test (FIT) and fecal calprotectin (Fcal) results are useful biomarkers for ulcerative colitis (UC). However, the situations in which each marker should be used are largely... -
- CITED
-
- Close
- SHARE
-
- Close
- An Elevated Platelet Count Increases the Risk of Relapse in Ulcerative Colitis Patients with Mucosal Healing
-
Nakarai A, Kato J, Hiraoka S, Takashima , Inokuchi T, Takahara M, Sugihara Y, Harada K, Okada H
- KMID: 2417308
- Gut Liver.
- 2018 Jul;12(4):420-425.
- doi: 10.5009/gnl17236
BACKGROUND/AIMS: Although mucosal healing (MH) has been considered a treatment goal for patients with ulcerative colitis (UC), the risk factors predictive of relapse in patients who achieve MH are unknown.... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
-
Hiraoka S, Takashima , Kondo Y, Inokuchi T, Sugihara Y, Takahara M, Kawano S, Harada K, Kato J, Okada H
- KMID: 2402650
- Intest Res.
- 2018 Jan;16(1):75-82.
- doi: 10.5217/ir.2018.16.1.75
BACKGROUND/AIMS: The efficacy of anti-tumor necrosis factor α (anti-TNFα) antibodies for postoperative Crohn's disease (CD) in patients who were treated with these agents prior to surgery is largely unknown. METHODS: CD... -
- CITED
-
- Close
- SHARE
-
- Close
- The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces
-
Hiraoka S, Takashima , Inokuchi T, Nakarai A, Takahara M, Harada K, Seki Y, Watanabe K, Kato J, Okada H
- KMID: 2449961
- Intest Res.
- 2019 Apr;17(2):202-209.
- doi: 10.5217/ir.2018.00086
BACKGROUND/AIMS: Fecal calprotectin (Fcal) as well as the fecal immunochemical test (FIT) are useful biomarkers for detecting activity and mucosal healing in inflammatory bowel diseases. Here, we report the performance... -
- CITED
-
- Close
- SHARE
-
- Close
